Lingohr & Partner Asset Management Gmb H United Therapeutics Corp Transaction History

Lingohr & Partner Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $650,921 - $1.03 Million	-8,558 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$107.15 - $126.84 $32,145 - $38,052	-300 Reduced 3.39%	8,558 $1 Million
Q4 2018 Feb 11, 2019	SELL	$101.4 - $128.73 $134,355 - $170,567	-1,325 Reduced 13.01%	8,858 $930,000
Q3 2018 Oct 18, 2018	SELL	$113.81 - $129.46 $217,263 - $247,139	-1,909 Reduced 15.79%	10,183 $1.3 Million
Q2 2018 Aug 15, 2018	SELL	$101.14 - $118.31 $118,434 - $138,541	-1,171 Reduced 8.83%	12,092 $1.37 Million
Q1 2018 Apr 26, 2018	BUY	$107.21 - $151.94 $209,595 - $297,042	1,955 Added 17.29%	13,263 $1.49 Million
Q4 2017 Jan 19, 2018	BUY	$118.58 - $151.28 $41,977 - $53,553	354 Added 3.23%	11,308 $1.67 Million
Q3 2017 Nov 06, 2017	BUY	$114.6 - $136.81 $1.26 Million - $1.5 Million	10,954	10,954 $1.31 Million

643

45.2M

368K

410K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.